Prospective Validation of Prostate Biomarkers for Repeat Biopsy: The PRIORITY Study
Study of Diagnostic Tests for Prostate Cancer
Sponsor: MDxHealth
Enrolling: Male Patients Only
IRB Number: AAAR2603
U.S. Govt. ID: NCT03082274
Contact: Research Nurse Navigator: 212-342-5162 / cancerclinicaltrials@cumc.columbia.edu
Additional Study Information: This study is being conducted to evaluate the performance of the ConfirmMDx and SelectMDx tests for Prostate Cancer to identify patients with increased risk for clinically significant disease, to ultimately lower the rate of repeat biopsies. Approximately 1000 people are expected to take part in this study.
This study is closed
Investigator
Sven Wenske, MD
Do You Qualify?
Are you male between the ages of 40 and 85? Yes No
Have you undergone a previous cancer-negative prostate biopsy in the past 30 months? Yes No
Have you been diagnosed with prostate cancer in any previous biopsy? Yes No
Do you have a history of cancer? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder



Cancel
For more information, please contact:
Research Nurse Navigator
cancerclinicaltrials@cumc.columbia.edu
212-342-5162
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE